EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity

Weilong Deng, Junyu Chen, Yingyue Pang, Yuanyuan Zhang, Siqian Chen, Guoliang You, Xiaoman Tian, Zhongxin Xu, Jing Wang, Luqing Shang iD

Advanced Science · 2026

DOI: 10.1002/advs.76662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Weilong Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, KLMDASR of Tianjin and Drug Discovery Center for Infectious Disease, Nankai …. Hauptthemen laut MEDLINE: Antiviral Agents, 3C Viral Proteases, Drug Resistance, Viral, Viral Proteins. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Guangzhou Laboratory, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diseases caused by picornaviruses pose a serious threat to society due to their high contagiousness and widespread prevalence. Beyond the poliovirus vaccine, antiviral therapeutics remain unavailable for most picornaviral infections. Moreover, existing inhibitors under development generally exhibit narrow‐spectrum activity and low barriers to resistance owing to the high mutability of RNA viral proteins. To address these issues, this study constructed a proteolysis‐targeting chimera (PROTAC) targeting the 3C protease (3C Pro ) — a key viral enzyme essential for picornavirus protein processing, host shutoff, and immune suppression. In enterovirus 71 (EV71), a representative member of the picornavirus family, experimental results showed that PROTAC molecule effectively inhibits viral replication through a dual mechanism of action: directly inhibiting the catalytic function of the 3C Pro and inducing its degradation via the ubiquitin‐proteasome pathway. Moreover, this PROTAC molecule not only demonstrated effective degradation of previously reported and AI‐predicted potential drug‐resistant EV71 mutants, but also exhibited degradation activity against 3C Pro from multiple picornaviruses, indicating its potential for broad‐spectrum antiviral activity. By integrating multidisciplinary approaches, this work demonstrates that targeted protein degradation can effectively induce the degradation of 3C Pro in picornaviruses, supporting the development of resistance‐resistant, broad‐spectrum antiviral agents and highlighting their potential to address evolving viral threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral Agents3C Viral ProteasesDrug Resistance, ViralViral ProteinsEnterovirus A, HumanCysteine EndopeptidasesProteolysis Targeting ChimeraHumansVirus ReplicationProteolysisPicornaviralesAnimals

Stichwörter der Autor:innen

3C proteasePROTACbroad‐spectrum activitydrug‐resistant mutationspicornavirus

Substanzen

Proteolysis Targeting ChimeraAntiviral Agents3C Viral ProteasesViral ProteinsCysteine Endopeptidases

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, KLMDASR of Tianjin and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, People's Republic of China.

ORCID-Profile: Luqing Shang

Förderung

  • National Natural Science Foundation of China
  • R&D Program of Guangzhou Laboratory
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Deng, W., Chen, J., Pang, Y., Zhang, Y., Chen, S., You, G., Tian, X., Xu, Z., Wang, J., & Shang, L. (2026). Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity. Advanced Science. https://doi.org/10.1002/advs.76662

Vancouver

Deng W, Chen J, Pang Y, Zhang Y, Chen S, You G, et al. Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity. Advanced Science. 2026. doi:10.1002/advs.76662

BibTeX
@article{Deng2026,
  author = {Deng, Weilong and Chen, Junyu and Pang, Yingyue and Zhang, Yuanyuan and Chen, Siqian and You, Guoliang and Tian, Xiaoman and Xu, Zhongxin and Wang, Jing and Shang, Luqing},
  title = {Targeted Degradation of Picornaviral 3C Protease via PROTACs Confers High Barrier to Viral Resistance and Broad‐Spectrum Antiviral Activity},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76662}
}
Kostenlos starten →